Niche Science & Technology Ltd published a breakthrough study in which researchers discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models even after repeated treatment cycles.
Published
Signal category
Research & Knowledge
Quote
“researchers discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated treatment cycles”
— Tim Hardman|Niche Science & Technology Ltd team
Company
Niche Science & Technology Ltd
Sharing our enthusiasm for science
- Industry
- Pharmaceutical Manufacturing
- Location
- Richmond, GB
- Company size
- 32 employees
Niche Science & Technology Ltd has provided a comprehensive clinical research service to a growing number of pharmaceutical clients since its inception in 1998. Specialising in medical writing and clinical project management, we are experts at ensuring our clients successfully progress their assets through all phases of clinical development. Study Reports, CSR’s, CTA’s/IND’s, IMPD's, Clinical Study Management, Protocols, Ethics Submissions, Investigator Brochures, TMF management, CTDs/Submissions, Manuscripts/Journal Submissions, Data Management and Stats Analysis, Marketing Projects, Product Positioning, Training Packages, SOP’s, Communications Strategies
Founded 1998